Evidence map›Paper›PMID 41806279›Full record

ReviewAdvances in therapy2026

Inhaled Corticosteroid/Long-Acting β

John D Blakey, Lorenzo Cecchi, Christian Domingo, Tony D D'Urzo, Dave Singh, Manish Verma

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Advances in therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

John D BlakeyRespiratory Medicine, Sir Charles Gairdner Hospital, Perth, WA, Australia.
Lorenzo CecchiAllergy and Immunology Unit, San Giovanni di Dio Hospital, USL Toscana Centro, Florence, Italy.
Christian DomingoDepartment of Pulmonary Medicine, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Spain. CDomingo@tauli.cat.
Tony D D'UrzoPrimary Care Lung Clinic, University of Toronto, Toronto, ON, Canada.
Dave SinghMedicines Evaluation Unit, Manchester, UK.
Manish VermaGlobal Medical Affairs, General Medicine, GSK, Mumbai, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current standard of maintenance care for patients with moderate-to-severe asthma is the use of inhaled corticosteroid/long-acting β

Indexed as

Adrenal Cortex HormonesAdrenergic beta-2 Receptor AgonistsAnti-Asthmatic AgentsAsthmaAdministration, InhalationClinical Decision-MakingHumansRandomized Controlled Trials as TopicSeverity of Illness IndexAdrenal Cortex HormonesAdrenergic beta-2 Receptor AgonistsAnti-Asthmatic AgentsAsthmaEffectivenessInhaled corticosteroidLong-acting β2-agonistReal world evidenceShared decision-making

Identifiers

PMID41806279
PMCPMC13156210

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.